← Eichor
Study identifier: NCT07192393 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).

Condition: Prematurity; Extreme · Prematurity; Decision Support · Necrotising Enterocolitis  ·  Sponsor: Imperial College London

PhaseN/A
Planned participants90
Who can joinAll sexes, N/A to 30 Weeks
Healthy volunteersNo

About this study

PREM-IMPACT is a UK-based observational study exploring how caring for a very premature baby-particularly one affected by necrotising enterocolitis (NEC)-impacts families over the first year after hospital discharge. NEC is a serious bowel disease that can occur in premature babies, often requiring surgery and prolonged hospitalisation. This study runs alongside the WHEAT International Trial, which investigates whether pausing or continuing milk feeds during blood transfusions affects the risk of NEC in very preterm babies. PREM-IMPACT acts as a nested economic evaluation of the WHEAT Trial, helping to understand whether different feeding practices around transfusion offer good value for money from both the NHS and family perspective. PREM-IMPACT will collect detailed data on babies' health-related quality of life, as well as the financial, emotional, and social impact on parents and siblings. Families are recruited from neonatal units when their baby is ready to go home and complete questionnaires at three timepoints: 1) just before discharge, 2) six months later, and 3) twelve months later. Questionnaires cover health, wellbeing, healthcare use, and costs to the family (such as travel, time off work, or extra care needs). A dedicated research nurse based at the lead NHS site helps coordinate follow-up centrally. By studying families of babies with and without NEC, this project aims to clarify the burden of prematurity and NEC on infant outcomes and family wellbeing. The …

This description comes directly from the study's public registry record.

Talk to the study team

Joe Montebello, MSc  ·  +442075947271  ·  j.montebello@imperial.ac.uk

Always discuss trial participation with your own doctor first.

Locations (7)

Norfolk and Norwich University HospitalNorwich, Norfolk, United KingdomRecruiting
University Hospital CoventryCoventry, United KingdomRecruiting
Liverpool Women's HospitalLiverpool, United KingdomRecruiting
Chelsea & Westminster HospitalLondon, United KingdomRecruiting
Imperial College Healthcare NHS Trust (St Mary's Hospital, Paddington)London, United KingdomRecruiting
John Radcliffe HospitalOxford, United KingdomRecruiting
Queen Alexandra HospitalPortsmouth, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07192393